Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jun;13(2):198.
doi: 10.1007/s13181-017-0610-z. Epub 2017 Mar 10.

In Response to Letter to the Editor Regarding: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review

Affiliations
Comment

In Response to Letter to the Editor Regarding: Cannabinoid Hyperemesis Syndrome: Diagnosis, Pathophysiology, and Treatment-a Systematic Review

Cecilia J Sorensen et al. J Med Toxicol. 2017 Jun.
No abstract available

Keywords: Cannabinoid hyperemesis syndrome; Cannabis; Cyclic vomiting syndrome; Haloperidol; Marijuana.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest

Dr. Sorensen and Kristen DeSanto declare that they have no conflicts of interest.

Sources of Funding

Dr. Borgelt receives support from the Colorado Department of Public Health and Environment and the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences. Dr. Phillips receives support from NIH on Drug Abuse R15 DA041656 and R01 DA034957, and Dr. Monte receives support from NIH 1 K23 GM110516 and NIH CTSI UL1 TR001082.

Comment on

References

    1. Witsil JC, Mycyk MB. Haloperidol, a novel treatment for cannabinoid hyperemesis syndrome. Am J Ther. 2017;24(1):e64–e67. doi: 10.1097/MJT.0000000000000157. - DOI - PubMed
    1. Hickey JL, Witsil JC, Mycyk MB. Haloperidol for treatment of cannabinoid hyperemesis syndrome. Am J Emerg Med. 2013;31(6):1003.e5–1003.e6. doi: 10.1016/j.ajem.2013.02.021. - DOI - PubMed
    1. Inayat, F., et al., Is haloperidol the wonder drug for cannabinoid hyperemesis syndrome? BMJ Case Rep, 2017. 2017 - PMC - PubMed
    1. Jones JL, Abernathy KE. Successful treatment of suspected cannabinoid hyperemesis syndrome using haloperidol in the outpatient setting. Case Rep Psychiatry. 2016;2016:3614053. - PMC - PubMed

Publication types

LinkOut - more resources